In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice
Cristian Berce,1,* Ciprian Lucan,2,* Bobe Petrushev,3,4 Sanda Boca,5 Mirela Miclean,6 Orsolya Sarpataki,7 Simion Astilean,5 Anca Buzoianu,8 Ciprian Tomuleasa,3,9 Anca Bojan9,10 1Animal Facility, 2Department of Surgery, 3Research Center for Functional Genomics and Translational Medicine, 4Department...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d1b0fa71a93497d967ffb4ef0d549a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9d1b0fa71a93497d967ffb4ef0d549a3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9d1b0fa71a93497d967ffb4ef0d549a32021-12-02T00:35:52ZIn vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice1178-2013https://doaj.org/article/9d1b0fa71a93497d967ffb4ef0d549a32016-09-01T00:00:00Zhttps://www.dovepress.com/in-vivo-assessment-of-bone-marrow-toxicity-by-gold-nanoparticle-based--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Cristian Berce,1,* Ciprian Lucan,2,* Bobe Petrushev,3,4 Sanda Boca,5 Mirela Miclean,6 Orsolya Sarpataki,7 Simion Astilean,5 Anca Buzoianu,8 Ciprian Tomuleasa,3,9 Anca Bojan9,10 1Animal Facility, 2Department of Surgery, 3Research Center for Functional Genomics and Translational Medicine, 4Department of Pathology, Iuliu Hatieganu University of Medicine and Pharmacy, 5Nanobiophotonics and Laser Microscopy Center, Interdisciplinary Research in Bio-Nano-Sciences – Faculty of Physics, Babes-Bolyai University, 6Institute for Research in Analytical Instruments, 7Department of Pathophysiology, University of Veterinary Medicine, 8Department of Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 9Department of Hematology, Ion Chiricuta Oncology Institute, 10Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania *These authors contributed equally to this work Introduction: The present study aimed at evaluating the biodistribution of Tween® 20-gold nanoparticle (GNP) conjugates and their potential toxicity on the bone marrow before moving on to Phase I clinical trials.Materials and methods: Tween® 20-conjugated GNPs were injected intravenously for 21 days in male Crl:CD1(ICR) mice. Body weight of the mice was evaluated each day. After the sub-chronic Tween® 20-GNPs administration, blood samples were harvested, and a full blood count was done individually. Total Au quantity from all major organs was assessed using inductively coupled plasma mass spectrometry. One femur and the sternum obtained from each animal were used for histological assessment.Results: Our data showed that the Tween® 20-GNP conjugates were found in large quantities in the bladder. Au was shown to accumulate in the hematopoietic bone tissue, with significant side effects such as leucopoiesis and megakaryopoiesis. The mice had a higher white blood cell and platelet count as opposed to the control group. This suggested that the previously described leukopenic effects of isoflurane were overridden by the leucopoietic effects of Tween® 20-GNPs.Conclusion: It was uncertain whether the mice were reactive to Au as it is a foreign substance to the tissues or whether the side effects observed were a precursor condition of a more severe hematological condition. Au was found to be hepatotoxic, urging the need for further studies in order to achieve better in vivo compliance and exploit the immense potential of GNPs in cancer pharmacology. Keywords: GNPs, Tween® 20, in vivo toxicologyBerce CLucan CPetrushev BBoca SMiclean MSarpataki OAstilean SBuzoianu ATomuleasa CBojan ADove Medical Pressarticlegold nanoparticlesTWEEN® 20in vivo toxicologyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 4261-4273 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
gold nanoparticles TWEEN® 20 in vivo toxicology Medicine (General) R5-920 |
spellingShingle |
gold nanoparticles TWEEN® 20 in vivo toxicology Medicine (General) R5-920 Berce C Lucan C Petrushev B Boca S Miclean M Sarpataki O Astilean S Buzoianu A Tomuleasa C Bojan A In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice |
description |
Cristian Berce,1,* Ciprian Lucan,2,* Bobe Petrushev,3,4 Sanda Boca,5 Mirela Miclean,6 Orsolya Sarpataki,7 Simion Astilean,5 Anca Buzoianu,8 Ciprian Tomuleasa,3,9 Anca Bojan9,10 1Animal Facility, 2Department of Surgery, 3Research Center for Functional Genomics and Translational Medicine, 4Department of Pathology, Iuliu Hatieganu University of Medicine and Pharmacy, 5Nanobiophotonics and Laser Microscopy Center, Interdisciplinary Research in Bio-Nano-Sciences – Faculty of Physics, Babes-Bolyai University, 6Institute for Research in Analytical Instruments, 7Department of Pathophysiology, University of Veterinary Medicine, 8Department of Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 9Department of Hematology, Ion Chiricuta Oncology Institute, 10Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania *These authors contributed equally to this work Introduction: The present study aimed at evaluating the biodistribution of Tween® 20-gold nanoparticle (GNP) conjugates and their potential toxicity on the bone marrow before moving on to Phase I clinical trials.Materials and methods: Tween® 20-conjugated GNPs were injected intravenously for 21 days in male Crl:CD1(ICR) mice. Body weight of the mice was evaluated each day. After the sub-chronic Tween® 20-GNPs administration, blood samples were harvested, and a full blood count was done individually. Total Au quantity from all major organs was assessed using inductively coupled plasma mass spectrometry. One femur and the sternum obtained from each animal were used for histological assessment.Results: Our data showed that the Tween® 20-GNP conjugates were found in large quantities in the bladder. Au was shown to accumulate in the hematopoietic bone tissue, with significant side effects such as leucopoiesis and megakaryopoiesis. The mice had a higher white blood cell and platelet count as opposed to the control group. This suggested that the previously described leukopenic effects of isoflurane were overridden by the leucopoietic effects of Tween® 20-GNPs.Conclusion: It was uncertain whether the mice were reactive to Au as it is a foreign substance to the tissues or whether the side effects observed were a precursor condition of a more severe hematological condition. Au was found to be hepatotoxic, urging the need for further studies in order to achieve better in vivo compliance and exploit the immense potential of GNPs in cancer pharmacology. Keywords: GNPs, Tween® 20, in vivo toxicology |
format |
article |
author |
Berce C Lucan C Petrushev B Boca S Miclean M Sarpataki O Astilean S Buzoianu A Tomuleasa C Bojan A |
author_facet |
Berce C Lucan C Petrushev B Boca S Miclean M Sarpataki O Astilean S Buzoianu A Tomuleasa C Bojan A |
author_sort |
Berce C |
title |
In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice |
title_short |
In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice |
title_full |
In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice |
title_fullStr |
In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice |
title_full_unstemmed |
In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice |
title_sort |
in vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in crl:cd1(icr) mice |
publisher |
Dove Medical Press |
publishDate |
2016 |
url |
https://doaj.org/article/9d1b0fa71a93497d967ffb4ef0d549a3 |
work_keys_str_mv |
AT bercec invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT lucanc invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT petrushevb invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT bocas invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT micleanm invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT sarpatakio invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT astileans invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT buzoianua invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT tomuleasac invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice AT bojana invivoassessmentofbonemarrowtoxicitybygoldnanoparticlebasedbioconjugatesincrlcd1icrmice |
_version_ |
1718403635036028928 |